Honore Tage
SEC CIK 1967946 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Dir | 135.1K | — | $240.9K | 6 | 2023-03-15 | 2026-06-04 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:17 | 2026-06-04 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | A - Grant | $0.00 | +41.6K | 135.1K | +45% | $0 | |
| 2026-02-24 | 2026-02-23 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | S - Sale | $8.03 | -30.0K | 93.5K | -24% | -$240.9K | |
| 2025-06-09 | 2025-06-05 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | A - Grant | $0.00 | +59.2K | 123.5K | +92% | $0 | |
| D | 2024-05-21 | 2024-05-17 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | A - Grant | $0.00 | +20.5K | 64.2K | +47% | $0 |
| D | 2023-06-12 | 2023-06-08 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | A - Grant | $0.00 | +17.3K | 43.7K | +66% | $0 |
| D | 2023-03-17 | 2023-03-15 | VNDA | Vanda Pharmaceuticals Inc. | Honore Tage | Dir | A - Grant | $0.00 | +26.4K | 26.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations